Business
Harrow to Present at Two Investor Conferences in May
NASHVILLE, Tenn.--(BUSINESS WIRE)-- Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that management will
About this update from Harrow, Inc.
[{"type":"text","content":" NASHVILLE, Tenn.--(BUSINESS WIRE)--\nHarrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that management will participate in the following two investor conferences in May:\n\nB. Riley Securities 25th Annual Investor Conference (The Ritz-Carlton, Marina del Rey, CA)\nFormat: Fireside Chat, followed by 1x1 Investor Meetings\nDate/Time: Wednesday, May 21, 2025, through Thursday, May 22, 2025\n\nCraig-Hallum 22nd Annual Institutional Investor Conference (Depot Renaissance Hotel, Minneapolis, MN)\nFormat: 1x1 and Small Group Investor Meetings\nDate/Time: Wednesday, May 28, 2025\n\nInvestors interested in meeting with management during either conference should contact their B. Riley or Craig-Hallum representative to request a meeting. Neither event will be webcast.\n\nAbout Harrow\n\nHarrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market. Harrow helps eyecare professionals preserve the gift of sight by making its portfolio of pharmaceutical products accessible and affordable to millions of patients each year. For more information about Harrow, please visit harrow.com.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20250514227378/en/\n\nJamie Webb, Director of Communications and Investor Relations\[email protected]\n615-733-4737\n\nSource: Harrow, Inc.","length":2829,"tagName":"div"}]